Combined sales of 5 leading firms up 12 percent in 2006

The combined earnings of five drug makers, which ended its fiscal year in March, posted 1.7 trillion won in 2006, up 11.5 percent compared with 965.1 billion won a year earlier, according to Yakup Shinmoon.

Daewoong Pharm garnered 70.2 billion won in operating profits on increased sales of Olmetec (olmesartan), an antihypertensive agent. The company also recorded 48.3 billion won in pr...